Stock analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.
Navidea Biopharmaceuticals Trading Down 50.0 %
Shares of Navidea Biopharmaceuticals stock opened at $0.00 on Friday. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.13.
About Navidea Biopharmaceuticals
See Also
- Five stocks we like better than Navidea Biopharmaceuticals
- The 3 Best Blue-Chip Stocks to Buy Now
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Using the MarketBeat Dividend Yield Calculator
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Basic Materials Stocks Investing
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.